v3.26.1
CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY (DEFICIT) - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Treasury Stock
Beginning balance (in shares) at Dec. 31, 2024   9,188,513      
Beginning balance at Dec. 31, 2024 $ (9,860) $ 1 $ 297,166 $ (307,027)  
Beginning balance (in shares) at Dec. 31, 2024         10,514
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Stock-based compensation 1,026   1,026    
Vesting of restricted stock units (in shares)   1,000      
Net (loss) income (9,742)     (9,742)  
Ending balance (in shares) at Mar. 31, 2025   9,189,513      
Ending balance at Mar. 31, 2025 (18,576) $ 1 298,192 (316,769)  
Ending balance (in shares) at Mar. 31, 2025         10,514
Beginning balance (in shares) at Dec. 31, 2024   9,188,513      
Beginning balance at Dec. 31, 2024 (9,860) $ 1 297,166 (307,027)  
Beginning balance (in shares) at Dec. 31, 2024         10,514
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net (loss) income (9,538)        
Ending balance (in shares) at Jun. 30, 2025   9,265,039      
Ending balance at Jun. 30, 2025 (17,484) $ 1 299,080 (316,565)  
Ending balance (in shares) at Jun. 30, 2025         10,514
Beginning balance (in shares) at Mar. 31, 2025   9,189,513      
Beginning balance at Mar. 31, 2025 (18,576) $ 1 298,192 (316,769)  
Beginning balance (in shares) at Mar. 31, 2025         10,514
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Stock-based compensation 888   888    
Exercised of pre-funded warrants (in shares)   70,100      
Vesting of restricted stock units (in shares)   5,426      
Net (loss) income 204     204  
Ending balance (in shares) at Jun. 30, 2025   9,265,039      
Ending balance at Jun. 30, 2025 $ (17,484) $ 1 299,080 (316,565)  
Ending balance (in shares) at Jun. 30, 2025         10,514
Beginning balance (in shares) at Dec. 31, 2025 17,189,300 17,189,300      
Beginning balance at Dec. 31, 2025 $ 24,743 $ 2 349,654 (324,913)  
Beginning balance (in shares) at Dec. 31, 2025 10,514       10,514
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Stock-based compensation $ 897   897    
Issuance costs (9)   (9)    
Torii warrant expense 106   106    
Net (loss) income (9,682)     (9,682)  
Ending balance (in shares) at Mar. 31, 2026   17,189,300      
Ending balance at Mar. 31, 2026 $ 16,055 $ 2 350,648 (334,595)  
Ending balance (in shares) at Mar. 31, 2026         10,514
Beginning balance (in shares) at Dec. 31, 2025 17,189,300 17,189,300      
Beginning balance at Dec. 31, 2025 $ 24,743 $ 2 349,654 (324,913)  
Beginning balance (in shares) at Dec. 31, 2025 10,514       10,514
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net (loss) income $ (22,835)        
Ending balance (in shares) at Jun. 30, 2026 17,189,300 17,189,300      
Ending balance at Jun. 30, 2026 $ 4,307 $ 2 352,053 (347,748)  
Ending balance (in shares) at Jun. 30, 2026 10,514       10,514
Beginning balance (in shares) at Mar. 31, 2026   17,189,300      
Beginning balance at Mar. 31, 2026 $ 16,055 $ 2 350,648 (334,595)  
Beginning balance (in shares) at Mar. 31, 2026         10,514
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Stock-based compensation 1,213   1,213    
Torii warrant expense 192   192    
Net (loss) income $ (13,153)     (13,153)  
Ending balance (in shares) at Jun. 30, 2026 17,189,300 17,189,300      
Ending balance at Jun. 30, 2026 $ 4,307 $ 2 $ 352,053 $ (347,748)  
Ending balance (in shares) at Jun. 30, 2026 10,514       10,514